Clinical trials: Community-Acquired Pneumonia (CAP)
Community Acquired Pneumonia (CAP)
Local Antibiotic Delivery for Community Acquired Pneumonia
A randomized, double-blinded clinical pilot study to assess whether addition of inhaled levofloxacin 240 mg twice daily for three days leads to improved or worsened physiological status in CAP patients with and without…
- Trial name
- LANDCAP-1 (NCT06859450)
- Testing
- Levofloxacin
- Volunteers
- 36 people
- Sponsor
- Copenhagen Respiratory Research
Pneumonia, Community Acquired Pneumonia
Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
The hypothesis to be tested is that ticagrelor (Brilinta™) will reduce platelet activation and markers of inflammation in patients with pneumonia.
- Conditions
- Pneumonia, Community Acquired Pneumonia, Hospital Acquired Pneumonia, Acute Lung Injury
- Trial name
- XANTHIPPE (NCT01883869)
- Testing
- ticagrelor
- Where
- 2 sites in United States
- Volunteers
- 60 people
- Sponsor
- University of Kentucky